The observation that the expression levels of Bnip3 and PGC-1α correlated positively with those of RORα suggests a potential application of our findings to diagnostic and therapeutic interventions for NASH (Fig. 5b). This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatohepatitis.